title: Adenosine activates mesangial cell proliferation.
abstract: This study investigates the proliferative effect of adenosine (ADO) in cultured mesangial cells, and the possible mediation of A1 and/or A2 receptors in this proliferative effect of ADO. ADO (10(-5) M) induced a significant increase in the [3H]thymidine incorporation into DNA with respect to quiescent cells. This increase was similar to that obtained with the ADO A1 receptor agonist, R-PIA (10(-5) M), and with the ADO A2 receptor agonist, NECA (10(-5) M). Theophylline (10(-4) M), and ADO receptors inhibitor, completely inhibits the ADO-induced proliferation. The combinations NECA + A2 receptor antagonist, PD 116,948 (AT1, 10(-6) M) and PIA + A2 receptor antagonists, PD 115,199 (AT2, 10(-2) M) did not induce any significant difference with respect to cells maintained in control conditions. These findings demonstrate the proliferative effect of ADO in cultured mesangial cells, and that this effect is not specific to either of A1 or A2 receptors activation.
authors.affiliation: Instituto Reina Sofía de Investigacíon Nefrológica, Departamento de Fisiología y Farmacología, Universidad de Salamanca, Spain.
authors.forename: M
authors.initials: M
authors.lastname: MacLaughlin
authors.forename: C
authors.initials: C
authors.lastname: Martinez-Salgado
authors.forename: N
authors.initials: N
authors.lastname: Eleno
authors.forename: A
authors.initials: A
authors.lastname: Olivera
authors.forename: J M
authors.initials: JM
authors.lastname: Lopez-Novoa
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology*; D019830:Adenosine-5'-(N-ethylcarboxamide); D000818:Animals; D002118:Calcium / Q000493:pharmacokinetics; D002455:Cell Division / Q000187:drug effects*; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000096:biosynthesis; D005920:Glomerular Mesangium / Q000166:cytology / Q000187:drug effects*; D010660:Phenylisopropyladenosine / Q000494:pharmacology; D058906:Purinergic P1 Receptor Agonists; D058915:Purinergic P1 Receptor Antagonists; D011687:Purines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013449:Sulfonamides / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D013936:Thymidine / Q000493:pharmacokinetics; D014970:Xanthines / Q000494:pharmacology; D000096926:Benzenesulfonamides
chemical_list: D000241:Adenosine; D019830:Adenosine-5'-(N-ethylcarboxamide); D002118:Calcium; D000242:Cyclic AMP; D010660:Phenylisopropyladenosine; D058906:Purinergic P1 Receptor Agonists; D058915:Purinergic P1 Receptor Antagonists; D011687:Purines; D013449:Sulfonamides; D013806:Theophylline; D013936:Thymidine; D014970:Xanthines; C052023:N-(2-(dimethylamino)ethyl)-N-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)benzenesulfonamide; D000096926:Benzenesulfonamides; C051360:1,3-dipropyl-8-cyclopentylxanthine